Neutralizing antibodies and clinical isolates of human immunodeficiency viruses (HIV).

Neutralizing antibodies and clinical isolates of human immunodeficiency viruses (HIV). - Neutralizing antibodies and clinical isolates ofHIV.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004720

Enrollment

Registered

2010-12-14

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with HIV-1 infection

Exclusion criteria

Exclusion criteria: 1.Patients who have difficulty to donate additional blood because of some complications such as severe anemia 2.Patients under treatment of immune suppressive agents or anti-cancer agents. 3.Patients under treatment with interferon. 4.Patients who are determined not appropriate for the study by attending doctors.

Design outcomes

Primary

Measure	Time frame
Establishment of neutralizing monoclonal antibodies against HIV. Isolation of HIV from patients with recent infection.	—

Countries

Japan

Contacts

Public ContactShuzo Matsushita

Kumamoto University Center for AIDS Research

shuzo@kumamoto-u.ac.jp096-373-6536

Outcome results